VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30

VitaNova Life Sciences Corp

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026

$4.50+0.50 (+12.50%)

Close on Oct 19, 2026

Market cap: $37.52M
P/E (TTM): –
Dividend yield: –

VitaNova Life Sciences Corp income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-04-30	FY 2025 2025-04-30	FY 2024 2024-04-30	FY 2023 2023-04-30	FY 2022 2022-04-30	FY 2021 2021-04-30	FY 2020 2020-04-30	FY 2019 2019-04-30	FY 2017 2017-01-25
Revenue	3.03	2.66	0.57	0.04	0.12	0	0	0	0
Cost of Revenue	2.11	1.09	0.19	0	–	–	–	0	0
Gross Profit	0.91	1.58	0.38	0.04	–	–	–	0	0
General & Administrative	0.73	0.16	0.09	0.06	0.13	0.05	0.07	0.07	0.01
Advertising Expenses	–	–	–	–	–	–	–	0	–
Operating Expenses	0.91	0.37	0.17	0.06	0.13	0.05	0.07	0.07	-0.01
Operating Income	0.00	1.21	0.21	-0.02	-0.01	-0.05	-0.07	-0.07	–
Interest Expense	0	0.00	0	–	–	–	–	–	–
Other Non-Operating Income	0.00	0.00	0.00	0	–	–	–	–	–
Pretax Income	0.01	1.20	0.21	-0.02	0.14	-0.05	-0.07	-0.07	–
Income Tax Expense	0.04	0.35	0.06	0	0	0	0	0	–
Income from Continuing Operations	–	–	–	–	–	–	–	-0.07	–
Income from Discontinued Operations	–	–	–	–	–	–	0	-0.03	–
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	-0.01
Net Income	-0.04	0.85	0.14	-0.02	0.14	-0.05	-0.07	-0.11	-0.01
EPS (Basic)(per share)	-0.0040	0.10	0.03	0.00	0.06	-0.03	0.00	0.00	–
EPS (Diluted)(per share)	–	0.09	0.03	0.00	0.06	-0.03	0.00	0.00	–
Shares Outstanding (Basic, Weighted)(shares)	8.34	8.34	3.55	1.96	1.96	1.96	1.96	1.96	–
Shares Outstanding (Diluted, Weighted)(shares)	8.34	8.34	3.55	1.96	1.96	1.96	1.96	1.96	1.17

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin: 26.9%
Operating margin: -2.7%
Net margin: -3.5%
Return on equity, FY2026: -1.9%

Financial strength

Current ratio: 7.13
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 514.7%

Valuation

P/E ratio: –
Price to sales: 11.57
Price to book: 19.46
Dividend yield: –